Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Fixed Capital/Sales

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   Fixed Capital/Sales(x) 0.760.820.890.620.48

What is the latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) ?

The latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) is 0.76 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.76
Mar20240.82
Mar20230.89
Mar20220.62
Mar20130.48

How is Fixed Capital/Sales of NATH BIOGENES (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.76
-7.32
Mar2024 0.82
-7.87
Mar2023 0.89
43.55
Mar2022 0.62
29.17
Mar2013 0.48 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Fixed Capital/Sales ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹283.5 Cr 6.8% 3.6% -4.8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,089.7 Cr 2.5% -10.8% -22% Stock Analytics
KAVERI SEED COMPANY ₹4,667.3 Cr 8.4% 21% -29.8% Stock Analytics
VENKYS (INDIA) ₹2,058.3 Cr 19.4% 13.8% -12.5% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,018.1 Cr 11% 14.4% -12.9% Stock Analytics
INDO US BIOTECH ₹213.5 Cr 2.2% -5.6% -28.2% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

6.8%

3.6%

-4.8%

SENSEX

4.8%

-4.2%

0.8%


You may also like the below Video Courses